Pfizer Inc (PFE) stock
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3046% above fair value
$29.45+0.09 (+0.31%)
Close on Nov 11, 2026Market cap $167.86BP/E 42.1Yield 5.84%
Pfizer gross margin
Gross margin is gross profit as a percentage of revenue.
Pfizer's gross margin for the twelve months ending Sep 27, 2026 was 73.4%. For fiscal 2025 it was 74.3%, against 71.9% the year before. The highest annual figure on record is 83.2% in fiscal 2008.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 74.3% | +2.4 |
| FY2024 | Dec 31, 2024 | 71.9% | +13.8 |
| FY2023 | Dec 31, 2023 | 58.1% | −8.0 |
| FY2022 | Dec 31, 2022 | 66.1% | +4.0 |
| FY2021 | Dec 31, 2021 | 62.1% | −17.5 |
| FY2020 | Dec 31, 2020 | 79.6% | −0.7 |
| FY2019 | Dec 31, 2019 | 80.3% | +2.3 |
| FY2018 | Dec 31, 2018 | 78.0% | −0.6 |
| FY2017 | Dec 31, 2017 | 78.6% | +2.0 |
| FY2016 | Dec 31, 2016 | 76.7% | −3.6 |
| FY2015 | Dec 31, 2015 | 80.3% | −0.4 |
| FY2014 | Dec 31, 2014 | 80.7% | −0.7 |
| FY2013 | Dec 31, 2013 | 81.4% | −0.6 |
| FY2012 | Dec 31, 2012 | 82.0% | +2.5 |
| FY2011 | Dec 31, 2011 | 79.5% | +2.2 |
| FY2010 | Dec 31, 2010 | 77.3% | −5.5 |
| FY2009 | Dec 31, 2009 | 82.8% | −0.4 |
| FY2008 | Dec 31, 2008 | 83.2% | +6.4 |
| FY2007 | Dec 31, 2007 | 76.8% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 27, 2026 | 75.7% | +0.8 |
| Q2 FY2026 | Jun 28, 2026 | 72.8% | −1.4 |
| Q1 FY2026 | Mar 29, 2026 | 75.4% | −3.8 |
| Q4 FY2025 | Dec 31, 2025 | 70.0% | +3.2 |
| Q3 FY2025 | Sep 28, 2025 | 74.9% | +4.7 |
| Q2 FY2025 | Jun 29, 2025 | 74.2% | −0.9 |
| Q1 FY2025 | Mar 30, 2025 | 79.3% | +2.0 |
| Q4 FY2024 | Dec 31, 2024 | 66.7% | +18.6 |
| Q3 FY2024 | Sep 29, 2024 | 70.3% | +39.0 |
| Q2 FY2024 | Jun 30, 2024 | 75.2% | +0.0 |
| Q1 FY2024 | Mar 31, 2024 | 77.3% | +3.7 |
| Q4 FY2023 | Dec 31, 2023 | 48.1% | −13.5 |
| Q3 FY2023 | Oct 1, 2023 | 31.3% | −41.9 |
| Q2 FY2023 | Jul 2, 2023 | 75.1% | +6.3 |
| Q1 FY2023 | Apr 2, 2023 | 73.6% | +12.5 |
| Q4 FY2022 | Dec 31, 2022 | 61.6% | +2.5 |
| Q3 FY2022 | Oct 2, 2022 | 73.2% | +14.5 |
| Q2 FY2022 | Jul 3, 2022 | 68.8% | +5.8 |
| Q1 FY2022 | Apr 3, 2022 | 61.1% | −10.3 |
| Q4 FY2021 | Dec 31, 2021 | 59.2% | −17.1 |
| Q3 FY2021 | Oct 3, 2021 | 58.7% | −21.8 |
| Q2 FY2021 | Jul 4, 2021 | 63.0% | −18.5 |
| Q1 FY2021 | Apr 4, 2021 | 71.4% | −9.4 |
| Q4 FY2020 | Dec 31, 2020 | 76.3% | +0.3 |
| Q3 FY2020 | Sep 27, 2020 | 80.5% | +1.0 |
| Q2 FY2020 | Jun 28, 2020 | 81.5% | +0.9 |
| Q1 FY2020 | Mar 29, 2020 | 80.8% | −0.7 |
| Q4 FY2019 | Dec 31, 2019 | 76.0% | +46.4 |
| Q3 FY2019 | Sep 29, 2019 | 79.5% | −0.3 |
| Q2 FY2019 | Jun 30, 2019 | 80.6% | +2.2 |
| Q1 FY2019 | Mar 31, 2019 | 81.5% | +1.3 |
| Q4 FY2018 | Dec 31, 2018 | 29.5% | −46.7 |
| Q3 FY2018 | Sep 30, 2018 | 79.7% | +1.3 |
| Q2 FY2018 | Jul 1, 2018 | 78.3% | −1.0 |
| Q1 FY2018 | Apr 1, 2018 | 80.1% | −0.5 |
| Q4 FY2017 | Dec 31, 2017 | 76.2% | −0.2 |
| Q3 FY2017 | Oct 1, 2017 | 78.4% | – |
| Q2 FY2017 | Jul 2, 2017 | 79.4% | – |
| Q1 FY2017 | Apr 2, 2017 | 80.7% | – |
| Q4 FY2016 | Dec 31, 2016 | 76.4% | – |
See a number that looks wrong?